Suggestions
Gregory Austin
QA/Regulatory/Engineering Consulting Solutions | Medical Device-Biotech-Pharma | Podcaster | Author | Speaker | Cultural Architect | Strategic Encourager
Gregory Austin, who uses the LinkedIn username gregoryaustin1, is the Business Development Lead at Enhanced Compliance Inc. (ECI). Here are some key points about his background and role:
Experience and Role
- At ECI, Gregory Austin helps pharmaceutical, biotechnology, and medical device companies solve complex problems related to commercial GMP (Good Manufacturing Practice) or Clinical Manufacturing. His expertise includes Facilities, Equipment, and Computer Systems Validation, as well as QA/Compliance and Audit support.123
Focus and Values
- His work is centered around patient safety and drug efficacy, ensuring compliance with FDA and global regulatory guidelines to improve patient health through safe medicines and devices.1
Professional Background
- Before joining ECI, Gregory Austin held various roles, including Business Development Manager at ProPharma Group, Recruiting Manager at STARTEK, and Conference Director at The Boston Society, Inc. These roles have equipped him with a broad range of skills in business development, recruitment, and event management.1
Current Responsibilities
- He creates partnerships and long-term business relationships with clients, often advising on outsourcing projects to maintain GMP manufacturing efficiency while reducing costs.1
Highlights
🎙️ New Episode Alert! ... In Episode 20 of BioTalk Unzipped, Dr. Chad Briscoe and I sit down with Dr. Jim Shen, Executive Director at Bristol Myers Squibb, to explore the cutting-edge advancements in cancer research that are transforming patient care.
Dr. Shen shares his unique journey from computer science to chemistry, and his deep passion for bioanalysis. We dive into: ✔️ The game-changing role of AI and mechanistic modeling in drug development. ✔️ Revolutionary cancer therapies and the hybrid treatments of small & large molecules. ✔️ Navigating the Complexities of Regulatory Submissions.
This episode is packed with insights for anyone in biotech, pharma, or oncology. Don't miss it!
https://lnkd.in/gTjBv_JM
#Cancer #Research #Bioanalysis #AI #DrugDevelopment #PharmaceuticalScience #Oncology #Biotechnology #Podcast
Join Dr. Chad Briscoe and I in our great conversation with Dr. Jim Shen of BMS on BioTalk Unzipped that starts tomorrow, September 1st.
Jim tells us about: ✔️ Advances in Cancer Research ✔️ His Journey into Bioanalysis ✔️ Integrating AI into Drug Development ✔️ Navigating the Complexities of Regulatory Submissions
You can find BioTalk Unzipped on YouTube, Apple, Spotify, Amazon, et al.
Check the comments for links to the show...
#cancer, #oncology. #research, #science, #AI, #FDA
